Results
76,369 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Mitchell Adrian VDirector |  SWKSTANLEY BLACK & DECKER, INC.Grant or award | A | $10K 120 sh | Jun 25, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Mitchell Adrian VDirector | SWKSTANLEY BLACK & DECKER, INC. Grant or award | A | $10K 120 sh | Jun 25, 2026 |
| 9 | Palmieri JaneDirector | SWKSTANLEY BLACK & DECKER, INC. Grant or award | A | $1,765 21 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 9 | Garrison John L JrDirector | SWKSTANLEY BLACK & DECKER, INC. Grant or award | A | $4,975 59 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 9 | Palmieri JaneDirector | SWKSTANLEY BLACK & DECKER, INC. Grant or award | A | $11K 129 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 9 | Morrell MarthaCHIEF MEDICAL OFFICER |  NPCENeuroPace IncTax withholding | F | $5,434 335 sh | Jun 25, 2026 traded Jun 24, 2026 |
| 7 | Ring ChristineChief Legal Officer |  NRIXNurix Therapeutics, Inc.Option exercise · 10b5-1 plan | M | $97K 13.3K sh | Jun 25, 2026 traded Jun 25, 2026 |
| 7 | Alclear Investments, LLCDirector, 10% Owner, See Remarks |  YOUClear Secure, Inc.Grant or award · 10b5-1 plan | A | — 196.6K sh | Jun 25, 2026 traded Jun 25, 2026 |
| 7 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $136K 15.6K sh | Jun 25, 2026 traded Jun 25, 2026 |
| 6 | Brown Christopher D.Director |  MASS908 Devices Inc.Open-market sale · 10b5-1 plan | SELL | $89K 9,900 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 5 | Coetzee MichaelVP and GM Fuel Syst. Americas |  PHINPHINIA INC.Grant or award | A | — 33 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 5 | Yang HongyongVP and GM Fuel Syst. Asia Pac | PHINPHINIA INC. Grant or award | A | — 4 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 5 | McCurry Jennifer LynnChief Accounting Officer |  LZBLA-Z-BOY INCTax withholding | F | $8,100 201 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 5 | Vidal DanielDirector |  EXFYExpensify, Inc.Grant or award | A | — 1.16M sh | Jun 25, 2026 traded Jun 23, 2026 |
| 5 | Bisharat JalehDirector |  WLTHWEALTHFRONT CORPGrant or award | A | — 19.4K sh | Jun 25, 2026 traded Jun 23, 2026 |
| 5 | Vasquez Alison GautEVP AND CFO |  ORNOrion Group Holdings IncTax withholding | F | $36K 2,325 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 5 | Garnett Timothy JohnDirector |  MPLTMapLight Therapeutics, Inc.Grant or award | A | — 14.9K sh | Jun 25, 2026 traded Jun 23, 2026 |
| 5 | Gardner Donald T. IIIChief Financial Officer |  KEQUKEWAUNEE SCIENTIFIC CORP /DE/Grant or award | A | — 5,428 sh | Jun 25, 2026 traded Jun 24, 2026 |
| 5 | Schaffer RyanDirector, Chief Financial Officer | EXFYExpensify, Inc. Grant or award | A | — 1.16M sh | Jun 25, 2026 traded Jun 23, 2026 |
| 5 | Mendelsohn AaronDirector |  VANIVivani Medical, Inc.Grant or award | A | $45K 36.5K sh | Jun 25, 2026 traded Jun 24, 2026 |
| 5 | Fryer NeilVP and GM Global Aftermarket | PHINPHINIA INC. Grant or award | A | — 34 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 5 | Leggett Michael AdamSr VP & Chief Supply Chain Off | LZBLA-Z-BOY INC Tax withholding | F | $21K 526 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 5 | Gustanski ChristopherVP, Operational Excellence | PHINPHINIA INC. Grant or award | A | — 25 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 5 | Mills Jason FahrDirector | EXFYExpensify, Inc. Grant or award | A | — 1.16M sh | Jun 25, 2026 traded Jun 23, 2026 |
| 5 | Pombier SamanthaVice President and Controller | PHINPHINIA INC. Grant or award | A | — 11 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 5 | Cordella Richard James JRDirector |  MVBFMVB FINANCIAL CORPOption exercise | M | — 3,701 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 5 | Williams GreggDirector, 10% Owner | VANIVivani Medical, Inc. Grant or award | A | $45K 36.5K sh | Jun 25, 2026 traded Jun 24, 2026 |
| 5 | Hull Thomas David IiiDirector, President & CEO | KEQUKEWAUNEE SCIENTIFIC CORP /DE/ Grant or award | A | — 15.2K sh | Jun 25, 2026 traded Jun 24, 2026 |
| 4 | Schlosser MarioDirector |  OSCROscar Health, Inc.Derivative conversion · 10b5-1 plan | C | — 880.0K sh | Jun 25, 2026 traded Jun 23, 2026 |
| 4 | Schlosser MarioDirector | OSCROscar Health, Inc. Derivative conversion · 10b5-1 plan | C | — 880.0K sh | Jun 25, 2026 traded Jun 23, 2026 |
| 3 | Bizily ScottChief Legal Officer |  FDMT4D Molecular Therapeutics, Inc.Option exercise · 10b5-1 plan | M | — 9,810 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 2 | Barrett David MichaelDirector, Chief Executive Officer | EXFYExpensify, Inc. Grant or award | A | — 2.09M sh | Jun 25, 2026 traded Jun 23, 2026 |
| 1 | Schlosser MarioDirector | OSCROscar Health, Inc. Open-market sale · 10b5-1 plan | SELL | $54K 1,799 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 0 | Doyle MittieChief Medical Officer |  AVTXAvalo Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $26K 1,450 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 0 | Schlosser MarioDirector | OSCROscar Health, Inc. Derivative conversion · 10b5-1 plan | C | — 47.5K sh | Jun 25, 2026 traded Jun 23, 2026 |
| 0 | Schlosser MarioDirector | OSCROscar Health, Inc. Option exercise · 10b5-1 plan | M | — 660.0K sh | Jun 25, 2026 traded Jun 23, 2026 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | YOUClear Secure, Inc. Disposition to issuer · 10b5-1 plan | D | — 196.6K sh | Jun 25, 2026 traded Jun 25, 2026 |
| 0 | Schmidt James FDirector, CFO, Treasurer, Secretary |  VICRVICOR CORPOption exercise · 10b5-1 plan | M | — 331 sh | Jun 25, 2026 traded Jun 24, 2026 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | YOUClear Secure, Inc. Grant or award · 10b5-1 plan | A | — 16.0K sh | Jun 25, 2026 traded Jun 24, 2026 |
| 0 | Doyle MittieChief Medical Officer | AVTXAvalo Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $12K 1,450 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 0 | Schlosser MarioDirector | OSCROscar Health, Inc. Derivative conversion · 10b5-1 plan | C | — 47.5K sh | Jun 25, 2026 traded Jun 23, 2026 |